| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00040157 Details | 2015-12-30 Interventional | 2 | - | Dexelvucitabine Acquired Immuno… HIV Infections Infections | Safety concerns - | |||
| NCT01893385 2012-005658-52 Details | 2015-12-23 Interventional | 2 | 37 | Vitamin D Avitaminosis Vitamin D Defic… D Vitamin Defic… | - - | |||
| NCT01624493 Details | 2015-12-23 Interventional | 1/2 | 0 | Carboplatin Gemcitabine Carcinoma, Ovar… Hypersensitivit… Ovarian Neoplas… Ovarian Cancer | Phase I was conducted Australia. Phase II not conducted and no US pts enrolled. - | |||
| NCT01802593 Details | 2015-12-22 Interventional | 4 | 20 | Azathioprine Mercaptopurine Methotrexate Crohn Disease Crohn's Disease | lack of budget and failure to reach milestones - | |||
| NCT00986284 Details | 2015-12-22 Interventional | 2 | 102 | Gefitinib Carcinoma, Non-… Lung Neoplasms Non Small Cell … | Lack of patients and some progressed disease soon after surgery - | |||
| NCT00866281 2008-006931-11 Details | 2015-12-22 Interventional | 1/2 | 22 | Midostaurin Leukemia Leukemia, Lymph… Leukemia, Myelo… Leukemia, Myelo… Precursor Cell … Acute Lymphobla… Acute Myeloid L… | Despite considerable efforts to boost recruitment during the final year of the study, no new
patients were enrolled. The study was terminated early since despite considerable efforts to boost recruitment, no new participants were enrolled in the final year of this study. | |||
| NCT01303250 2009-017595-25 Details | 2015-12-18 Interventional | 4 | 31 | Hydroxyethyl St… Surgery, Colore… | The final decision of the review of HES-containing solution shall be awaited. - | |||
| NCT01021176 Details | 2015-12-18 Interventional | 1 | 12 | Diltiazem Food Intake | - - | |||
| NCT00517582 Details | 2015-12-18 Interventional | 1 | 13 | Icatibant Angioedema Angioneurotic E… | This study was stopped to allow initiation of a mult-center study - | |||
| NCT00272025 Details | 2015-12-16 Interventional | 1 | 1 | Escitalopram Bipolar Disorde… Depression Depressive Diso… Bipolar Depress… | Lundbeck withdrew committment - expiring patents and prolonged inactivity - | |||
| NCT01880437 2013-001570-14 Details | 2015-12-15 Interventional | 2 | 38 | Cytarabine Leukemia Leukemia, Myelo… Leukemia, Myelo… Myelodysplastic… Preleukemia Syndrome Myelodysplastic… | - This study was prematurely terminated because of lower-than-expected efficacy observed in interim data analyses. | |||
| NCT01705808 Details | 2015-12-15 Interventional | 3 | - | Protein C Critical Illnes… Sepsis | - - | |||
| NCT02629848 Details | 2015-12-14 Interventional | 3 | 401 | Carboplatin Motesanib dipho… Paclitaxel Carcinoma, Non-… | Sponsor decision to terminate the study because the study did not meet the primary endpoint. - | |||
| NCT00047567 Details | 2015-12-14 Interventional | 4 | - | Zonisamide Bipolar Disorde… Bipolar Disorde… | - - | |||
| NCT02357732 Details | 2015-12-11 Interventional | 1 | 0 | Dabrafenib Nivolumab Trametinib Melanoma Metastatic Mela… | PI decided not to proceed - | |||
| NCT02281292 Details | 2015-12-11 Interventional | 1 | 0 | Ophthalmic Solu… Pharmaceutical … Ranibizumab Edema Macular Edema Diabetic Macula… | Management Decision - | |||
| NCT00636441 Details | 2015-12-11 Interventional | 2 | 56 | Cyclophosphamid… Docetaxel Doxorubicin Liposomal doxor… Breast Neoplasm… Early-Stage Bre… | Study terminated due to reproducibility issues with genomics prediction model - | |||
| NCT01675947 NCT01664208 Details | 2015-12-10 Interventional | 2 | 52 | Lidocaine Sirolimus Atrophy Geographic Atro… | On May 30, 2014, study injections were discontinued at the request of the DSMC. No further
recruitment will occur. - | |||
| NCT01530399 Details | 2015-12-10 Interventional | 2 | 44 | Tranexamic Acid Bleeding | Safety - | |||
| NCT01260467 Details | 2015-12-10 Interventional | 2 | 4 | Memantine Glioblastoma | - - |